Healthcare -
Biotechnology - NASDAQ - US
$ 6.58
-0.303 %
$ 326 M
Market Cap
-1.31
P/E
Price Target
Average
399.83%
Revenue Forecast
Estimate
80.77%
EBIT
Estimate
--9.93%
Net Income
Estimate
67.21%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
REGENXBIO Inc.
Wall Street analysts predict an average 1-year price target for RGNX of $32.9 , with forecasts ranging from
a
low of
$18 to a high of $40 .
RGNX Lowest Price Target
Wall Street Target
18 USD
173.56%
RGNX Average Price Target
Wall Street Target
32.9 USD
399.83%
RGNX Highest Price Target
Wall Street Target
40 USD
507.90%
REVENUE FORECAST
Revenue Forecast Chart RGNX
EBIT FORECAST
EBIT Forecast Chart RGNX
NET INCOME FORECAST
Net Income Chart RGNX